About David Licata
Form D filings for TORL Biotherapeutics in 2024 list David Licata as president and director.
David Licata first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Licata in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Licata works with at each company, as listed on that company's latest Form D.
TORL Biotherapeutics LLC · Form D, Apr 17, 2024
MA
Mark Alles
Executive officer and director
MA
Mark Attanasio
Director
NB
Neil O'Brien
Director
AS
Amit Sinha
Director
LS
Lynn Seely
Director
DS
Dennis Slamon
Director